Molecular Mechanisms and Targets

85 Items

All Items

WFDC3 identified as a prognostic and immune biomarker in pancreatic cancer

Bohan Liu, Xuqing Shi, Tianqi Liu, Huanwen Wu, Zhiyong Liang

2447–2465
VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels

Chunyu Zhu, Yameng Cheng, Yao Yu, Yanning Zhang, Guiyun Ren

1244–1257
VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

Lidija Todorović, Boban Stanojević

26-36
UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach

Kongfan Zhu, Hua Hu, Yuanfa Tao, Zhijian Yang, Hanjun Li

2466–2480
Unveiling the impact of C15orf48 on non-small cell lung cancer through NF-kappa B signaling

Wei Wang, Lei Zhang, Ansheng Wang, Xiaohua Wang, Weidong Wu

1162–1174
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy

Semir Vranic, Zoran Gatalica

673–675
Tumor hypoxia: Classification, detection, and its critical role in cancer progression

Yan Zhao, Bing Zhong, Jing-Yi Cao, Qian Wang, Jie Liang, Ke Lu, Sheng-Ming Lu

1672–1690
Tumor glucose reprogramming suppresses cuproptosis: A review

Xiao-Hang Song, Yi-Hang Ding, Jing-Song Chen

251–261
Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling

Hongyan Zhang, Ruiqing Zong, Huiqi Wu, Jun Jiang, Chuanyong Liu, Suiyi Liu

1606–1619
The mechanism of high mobility group box-1 protein and its bidirectional regulation in tumors

Zhongjia Tian, Lin Zhu, Yutong Xie, Huan Hu, Qunli Ren, Jianguo Liu, Qian Wang

477–485
TCF12 enhances angiogenesis and affects sorafenib response in liver cancer via HIF-1α interaction

Yuanbin Chen, Xiaolong Wang, Jin Chen, Min Dai, Xinyue Zhang, Jie Yin, Xiao He

1868–1881
Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level

Xingchao Song, Wenjin Li, Chunyan Tian, Xiao Ma, Weibin Yang, Jiahua Zhou

144–154
Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway

Hongmei Yin, Zhongxia Yuan, Xiumei Han, Die Jiang, Duojie Li, FengLi Song

1150–1161
SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

1231–1243
SMARCA4 deficiency in small cell lung cancer: A case report and narrative review of the literature

Andreas M. Matthaiou, Ioannis Tomos, Nikoleta Bizymi, Ioannis Vamvakaris, Nektarios Anagnostopoulos, Aikaterini Papadopoulou, Kalliopi Angelou, Grigoris Stratakos, Adamantia Liapikou

2394–2399
Silencing CACYBP suppresses lung adenocarcinoma growth via CDK1 inhibition

Ge Wen, Shaoqing Niu, Shiqi Mei, Senming Wang

1801–1815
Secreted frizzled-related protein 4 (sFRP4) in cancer – Dual roles in tumorigenesis and therapeutic potential: A review

Yu Jiang, Luyao Wang, Yerong Li, Juan Liu, Juan Lv, Pengfei Xu

274–284
Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis

Ge Yu, Xiaoling Feng

82–93
Role of gut microbiota and immune response in breast cancer progression

Xiaofang Zhang, Na Ma, Conghui Jin, Xiaoli Cao

100–114
Role of Fascin-1 in cervical cancer metastasis via Wnt/β-catenin pathway activation

Yan Wang, Wei Cui, Dong-Mei Chu

1789–1800

1-20 of 85 Next